Dr. Rafiq Hasan is the CEO of Complement Therapeutics and a Senior Advisor at BGV, with deep expertise in ophthalmology from senior roles at Bayer and Novartis. He holds a medical degree from the University of London and is known for successfully growing a multi-billion dollar franchise from its launch.
He is passionate about medical innovation and its impact on patients lives, dedicating time to mentoring biotech start-ups through programs at Wayra and the UK Clinical Entrepreneurship Programme. His career reflects a commitment to advancing novel therapies from the lab to patients who need them.
Dr. Hasan uniquely combines clinical practice experience with a track record in global commercial, medical, and market access leadership within the pharmaceutical industry.
Read the full overview →The only way to convince them is by showing them examples and ample proof. They are heavily focused on quality and prefer doing things the right way, even if it takes time. They tend to be clear about their needs and limitations and are unlikely to promise too much.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.